As a serious complication of cholelithiasis, gangrenous cholecystitis presents greater mortality than noncomplicated cholecystitis. The aim of this study was to specify the risk factors on mortality. 107 consecutive patients who underwent surgery due to gangrenous cholecystitis between January 1997 and October 2011 were investigated retrospectively. The study included 60 (56.1%) females and 47 (43.9%) males, with a mean age of 60.7 ± 16.4 (21–88) years. Cardiovascular diseases were the most frequently accompanying medical issues (24.3%). Thirty-six complications (33.6%) developed in 29 patients, and surgical site infection was proven as the most common. Longer delay time prior to hospital admission, low white blood cell count, presence of diabetes mellitus, higher blood levels of aspartate aminotransferase, alanine aminotransferase, alkaline phosphatase and total bilirubin, pericholecystic fluid in abdominal ultrasonography, and conversion from laparoscopic surgery to open surgery were identified as risk factors affecting mortality (P < 0.001, P = 0.001, P = 0.044, P = 0.005, P = 0.049, P = 0.009, P = 0.022, P = 0.011, and P = 0.004, respectively). Longer delay time prior to hospital admission and low white blood cell count were determined as independent risk factors affecting mortality.

Gangrenous cholecystitis (GC) is defined as necrosis and perforation of the gallbladder wall as a result of ischemia following progressive vascular insufficiency.1,2  GC is a severe complication of cholelithiasis.3,4  Factors such as male sex, advanced age, delayed surgery, leukocytosis, cardiovascular diseases (CVDs), and diabetes mellitus (DM) increase the likelihood of developing GC.3,58  Compared with uncomplicated acute cholecystitis, GC carries a significantly higher mortality rate, which has been reported to be between 15% and 50%.3,4  We aimed in this study to specify the risk factors affecting mortality in patients with GC who underwent surgery.

Case files from 107 consecutive patients with the diagnosis of GC who underwent a surgical operation in the Department of General Surgery, Faculty of Medicine, Dicle University, between January 1997 and October 2011 were retrospectively investigated. Age, sex, time of hospital admission, time of surgical operation undertaken, accompanying disease, laboratory findings at the admission [white blood cells (WBC), aspartate aminotransferase (AST), alanine aminotransferase (ALT), alkaline phosphatase (ALP), and total bilirubin], findings in abdominal ultrasonography and computed tomography (CT), length of hospital stay, complications, and mortality were recorded for each patient. The group of patients excluded from the study was composed of patients who were operated on after implementation of tube cholecystostomy and medical therapy. The definitive diagnosis of GC was established on patient's physical examination (pain in upper right abdominal quadrant, fever >37°C, positive Murphy's sign, and/or findings indicating peritoneal irritation), laboratory findings (WBC count, ALT, and AST elevations), radiologic findings, and detection of full-thickness necrotic areas along with infiltration by neutrophils and mononuclear cells in histologic sections.4,9  All cases were operated on within 24 hours of their presentation. A second-generation cephalosporin of 1 mg dosage was injected intravenously before the operation as a regimen for perioperative prophylaxis. Cholecystectomy was undertaken laparoscopically or as open procedure. Subcostal or median incisions were preferred in open cholecystectomy. In patients with extensive adhesions in whom sufficient anatomic exploration could not be performed, conversion to open laparotomy became inevitable owing to technical difficulties. Choledochal exploration and T-tube drainage were undertaken in patients in whom injury to choledoc was detected and in whom perioperative cholangiogram or palpation revealed stone in the choledocus8  The gallbladder fossa was copiously irrigated with normal saline, followed by insertion of a drain. The diagnosis of sepsis was established according the criteria identified by the American College of Chest Physicians and the Society of Critical Care Medicine (ACCP/SCCM).10  CVDs and respiratory diseases were defined as ischemic heart disease and/or heart failure and chronic obstructive pulmonary disease and/or asthma, respectively. The patients were subdivided into two groups: group 1 in which no mortality occurred, and group 2 in which mortality occurred. Age >51 years, sex, time period between the onset of symptoms and hospital admission, accompanying diseases (DM, CVD), laboratory findings (WBC: ≤ 4000/mm3, 4001–15,000/mm3, and >15,000/mm3); AST ≥ 43 U/L; ALT ≥ 50 U/L; ALP ≥ 200 U/L; and total bilirubin ≥ 1.2 mg/dL), and radiologic findings (identification of pericholecystic fluid, the thickness and the anatomic integrity of the gallbladder in all of the patients by ultrasonography (USG), and distension, wall thickening, pericholecystic inflammation, irregular or absent wall, and adjacent hepatic enhancements in 89 patients by CT examination) were evaluated as risk factors affecting mortality.5,11  USG was used in all our patients, but CT was performed only for 89 patients since the diagnoses of 18 patients were achieved by USG.

Statistical Analysis

Statistical analysis was performed using SPSS 15 program (SPSS Inc, Chicago, IL) during the evaluation of study results. Quantitative data were defined as mean ± SD. Mann-Whitney U test was used owing to nonhomogenous distribution of the independent variables. Multivariate logistic regression test was used to determine risk factors affecting mortality. P values < 0.05 were accepted to be significant.

Of the 107 patients, 60 (56.1%) were female and 47 (43.9%) were male, with a median age of 60.7 ± 16.4 years (21–88 years). Mean time delay to hospital admission was 21.7 ± 26.9 hours (2–112 hours). Choledochal exploration and T-tube insertion in addition to cholecystectomy were implemented in a total of 12 patients: in 9, stone was detected via cholangiography and palpation in the main bile ducts, and in 3, injury to the choledochus existed. The results from histopathologic examinations in all patients were compatible with GC. Table 1 shows the characteristics and demographics of the patients. A total of 63 accompanying diseases were detected in 44 of the cases; with CVDs ranking first, affecting 26 (24.3%) patients. A total of 36 (33.6%) complications were observed in 29 of the cases, the most common of which was surgical site infection. The accompanying diseases and the complications are shown in Table 2. Of all patients, 88 (88.2%) were assigned to group 1 and 19 (17.8%) to group 2. Upon making a comparison between the patients in whom mortality occurred (group 2) and those in whom mortality did not occur (group 1), significant difference was detected with regard to time to hospital admission, presence of DM, results of WBC count, AST, ALT, ALP and total bilirubin, detection of pericholecystic fluid collection in USG, wall thickening, pericholecystic inflammation, irregular or absent wall and adjacent hepatic enhancements on CT examination, and conversion from laparoscopic operation to open surgery (Table 3). Delayed admission to hospital and low WBC count were found to be independent risk factors affecting mortality (Table 4).

Table 1

Patients' demographic and characteristic findings

Patients' demographic and characteristic findings
Patients' demographic and characteristic findings
Table 2

Comorbidities and complications in patients

Comorbidities and complications in patients
Comorbidities and complications in patients
Table 3

The differences between the mortality and nonmortality groups in patients with gangrenous cholecystitis

The differences between the mortality and nonmortality groups in patients with gangrenous cholecystitis
The differences between the mortality and nonmortality groups in patients with gangrenous cholecystitis
Table 4

Multivariate logistic regression analysis of predicting factors for mortality of gangrenous cholecystitis

Multivariate logistic regression analysis of predicting factors for mortality of gangrenous cholecystitis
Multivariate logistic regression analysis of predicting factors for mortality of gangrenous cholecystitis

Acute cholecystitis develops in 1% to 2% of patients with asymptomatic cholelithiasis each year.12  Conservative treatment comprising intravenous fluid resuscitation and antibiotic therapy proves effective in 80% of patients with acute cholecystitis.13  As one of the severe complications of acute cholecystitis, GC develops in 2% to 20% of the cases with acute cholecystitis.5,6,14  Epithelial injury by increasing gallbladder wall tension owing to vascular insufficiency arising secondary to persistent obstruction of the cystic duct gives way to the development of GC, which follows a quite rapid course.5  The phospholipases released from cell membranes of damaged epithelium initiate heavy inflammatory reaction.1,2,5,15  Inflammation and ischemia of the gallbladder wall show progressive worsening as a result of deteriorating venous insufficiency with age, thereby giving rise to more necrosis and perforation.7,16,17  Although 73.8% of the cases in our study were aged 51 years and older, age did not influence mortality.

The risk of developing GC is higher in males compared with females.3,6  However, the fact that the incidence of cholelithiasis is higher in females than in males led to a relative abundance of female cases over males in our study. Furthermore, mortality occurred in 15% of female patients and in 21.1% of male patients in our study, which didn't reach the level of significance.

Making the diagnosis of GC is quite challenging in the preoperative period. Nonspecific physical examination and laboratory findings along with absence of the classic clinical symptoms and signs pointing out acute cholecystitis in the elderly may give rise both to missed diagnosis and to delayed implementation of treatment.5,18  Contini et al8  reported that delayed admission was an important criterion in the development of GC. Eldar et al17  reported worsening macroscopic alterations in the case of hospital admissions later than 48 hours. While the total mean time delay to hospital admission of our patients was 21 hours, it was 54 hours in those in whom mortality occurred. We believe that factors such as older age and poor awareness about diseases play a pivotal role in delayed admissions. Delayed admissions culminate in the development of peritonitis and impaired general condition in the affected patients. The results obtained from our study demonstrate that delayed admission was a crucial criterion regarding mortality.

It has been proposed that pathologies of the cystic artery emerging from atherosclerosis or microvascular diseases might lead to vascular insufficiency, therefore predisposing factors such as DM and CVD could be regarded as risk factors in development of GC.5,1921  However, in contrast to the former proposal, some other studies identify no direct relationship between development of GC and DM.37  In our study, 24.3% of cases had CVD and 19.6% had DM. Presence of DM was found to influence mortality.

A high degree of leukocytosis has been documented to be correlated with the infection severity in the gallbladder wall.22  Fagan et al5  and Aydın et al6  reported that WBC count >15,000/mm3 predicted development of GC, whereas it was 17,000/mm3 in the study by Merriam et al.3  The number of WBCs in the patients with GC in our study was detected to be high, yet the WBC count was found to be significantly lower in the patients with GC in whom mortality occurred. Girgin et al23  reported that a high WBC count put forth as a predictive factor in the development of GC decreased as sepsis developed, which might herald an increase in mortality rate. The presence of low WBC count and its negative correlation with the mortality rate in our study prompt us to consider that sepsis leads to mortality.

Elevation in serum liver enzymes indicates hepatocyte necrosis. GC-related inflammatory alterations in the gallbladder bed induce elevation liver enzymes.5,24  Accordingly, bilirubin levels elevate in the serum via edema and inflammation in the bile ducts and direct impingement of the hydropic gallbladder on the choledoc duct (Mirizzi syndrome).25  Polymorphonuclear leukocyte infiltration along with focal hepatic parenchymal necrosis was observed in biopsy specimens obtained from the GC patients with elevated enzymes.26  It was reported in our study that AST, ALT, ALP, and total bilirubin levels were elevated in the all of the patients; moreover, further elevations in the former markers were found in the cases in whom mortality occurred. This situation can be ascribed to the likelihood that elevation in the level of serum enzymes and bilirubin may point to deterioration of the gangrenous pathology in the gallbladder.

The inflammation and thickening of the gallbladder wall can be seen by USG in 90% to 95% of patients with GC.7  However, thickening of the wall and presence of pericholecystic fluid collection do not always indicate development of GC, but instead progression of the inflammation.7  Fagan et al5  reported that detection of pericholecystic fluid by USG predicted development of GC. In our study, edema and thickening of the gallbladder were documented via USG in all of the patients, whereas pericholecystic fluid collection was detected in 19.6% of the patients. Detection of pericholecystic fluid collection was found to be significant with regard to mortality.

Bennett et al11  reported that air in the gallbladder wall or lumen, irregular or absent gallbladder wall, intraluminal membranes, pericholecystic abscess, and lack of gallbladder wall enhancement are specific CT findings of acute cholecystitis complicated by gangrene. In our study, typical CT findings were present in 86.5% of the patients, but it was found to be insignificant over mortality.

Today, cholecystectomy undertaken through laparoscopic methods has become more and more widespread in the treatment of GC. The conversion rates, albeit reported to be 30% to 50% in previous studies,27,28  have recently dropped to 8.7%.7  No increase but a decrease in mortality and morbidity rates was reported with the implementation of laparoscopic cholecystectomy for GC.7,16  In our study, conversion from laparoscopic surgery to open surgery occurred in 14% of the patients. In addition, conversion to open surgery was dictated by difficulties in dissection due to adhesions, insufficient anatomic exploration, complications like bleeding and injury to bile ducts, and technical difficulties. Mortality was higher in cases in which conversion to open surgery occurred, which might be ascribed to the fact that laparoscopic cholecystectomy was undertaken in selected patients with less-severe inflammatory status.

Stones are detected in choledoc duct in 21% of patients with acute cholecystitis. The former ratio was determined to be 13% in patients with GC. Moreover, stones were identified preoperatively in 50% of the patients.29  As for our study, we detected choledochal stones in 8.4% of the patients. Since surgery under emergency conditions was undertaken in the patients with GC, no endoscopic retrograde cholangiopancreatography (ERCP) was performed. It was for this reason that choledochal exploration plus T-tube insertion was performed in the cases in which stones were detected intraoperatively in the choledoc duct. Now that T-tube implementation has been found not to effect mortality, we don't see any disadvantage with a simultaneous implementation of choledochal exploration, if needed, in patients with GC.

ERCP helps to diagnose and, when combined with endoscopic sphincterotomy and/or biliary stenting, to manage ERCP postcholecystectomy residual choledochal stones and postoperative biliary complications such as bile duct injuries with bile leakage or stricture.30 

Mortality and morbidity rate imposed by this disease is quite high compared with noncomplicated acute cholecystitis. Habib et al18  and Fry et al15  reported mortality rates of 50% and 40%, respectively, whereas our study documented that the morbidity rate was 29%, and the mortality rate was 17.8%. Despite high morbidity and mortality following surgery, emergency surgery should not be avoided considering the likelihood that delayed surgery may be associated with even higher levels of mortality and morbidity.5,31,32 

Nguyen et al31  and Fagan et al5  determined that DM, WBC ≥ 15,000 mm3, ALT ≥ 50 U/L, AST ≥ 43 U/L, ALP ≥ 200 U/L, older age (>51 years), and detection of pericholecystic fluid via USG are independent risk factors predicting development of GC, whereas our study found delayed admission to the hospital and low WBC count to be independent risk factors affecting mortality.

GC is a disease state that necessitates emergency treatment because of its high mortality rate. The presence of DM as accompanying disease, high levels of ALT, AST, ALP, and total bilirubin, detection of pericholecystic fluid in USG, and conversion from laparoscopic surgery to open surgery for technical reasons were observed significantly more frequently in the cases in which mortality occurred. Delayed admission to the hospital and low WBC count were found to be independent risk factors affecting mortality.

No conflict of interest was declared by the authors.

1
Stefanidis
D
,
Bingener
J
,
Richards
M
,
Schwesinger
W
,
Dorman
J
,
Sirinek
K
.
Gangrenous cholecystitis in the decade before and after the introduction of laparoscopic cholecystectomy
.
JSLS
2005
;
9
(
2
):
169
173
2
Stefanidis
D
,
Sirinek
KR
,
Bingener
J
.
Gallbladder perforation: risk factors and outcome
.
J Surg Res
2006
;
131
(
2
):
204
208
3
Merriam
LT
,
Kanan
SA
,
Dawes
LG
,
Angelos
P
,
Prystowsky
PJB
,
Renge
RV
et al
.
Gangrenous cholecystitis: analysis of risk factors and experience with laparoscopic cholecystectomy
.
Surgery
1999
;
126
(
4
):
680
685
4
Weiss
CA
III,
Lakshman
TV
,
Schwartz
RW
.
Current diagnosis and treatment of cholecystitis
.
Curr Surg
2002
;
59
(
1
):
51
54
5
Fagan
SP
,
Awad
SS
,
Rahwan
K
,
Hira
K
,
Aoiki
N
,
Itani
KMF
et al
.
Prognostic factors for the development of gangrenous cholecystitis
.
Am J Surg
2003
;
186
(
5
):
481
485
6
Aydın
C
,
Altaca
G
,
Berber
I
,
Tekin
K
,
Karam, Titiz I. Prognostic parameters for the prediction of acute gangrenous cholecystitis
.
J Hepatobiliary Pancreat Surg
2006
;
13
(
2
):
155
559
7
Hunt
DRH
,
Chu
CK
.
Gangrenous cholecystitis in the laparoscopic era
.
Aust N Z J Surg
2000
;
70
(
6
):
428
430
8
Contini
S
,
Corradi
D
,
Busi
N
,
Alessandri
L
,
Pezzarossa
A
,
Scarpicnato
A
.
Can gangrenous cholecystitis be prevented? A plea against a “wait and see” attitude
.
J Clin Gastroenterol
2004
;
38
(
8
):
710
716
9
Saul
SH
.
Gallbladder and extrahepatic biliary tree
.
In
:
Sternberg
SS AD
,
Carter
D
,
Mills
SE
,
Obermann
HA
,
eds
.
Diagnostic Surgical Pathology
.
3rd ed
.
Philadelphia, PA
:
Lippincott, Williams & Wilkins
,
1999
:
1629
1670
10
Levy
MM
,
Fink
MP
,
Marshall
JC
,
Abraham
E
,
Angus
D
,
Cook
D
et al
.
2001 SCCM/ESICM/ ACCP/ATS/SIS International Sepsis Definitions Conference
.
Crit Care Med
2003
;
31
(
4
):
1250
1256
11
Bennett
GL
,
Rusinek
H
,
Lisi
V
,
Israel
GM
,
Krinsky
GA
,
Slywotzky
CM
et al
.
CT findings in acute gangrenous cholecystitis
.
AJR
2002
;
178
(
2
):
275
281
12
Friedman
GD
.
Natural history of asymptomatic and symptomatic gallstones
.
Am J Surg
1993
;
165
(
4
):
399
404
13
Bedirli
A
,
Sakrak
O
,
Sozuer
EM
,
Kerek
M
,
Güler
I
.
Factors effecting the complications in the natural history of acute cholecystitis
.
Hepatogastroenterology
2001
;
48
(
41
):
1275
1278
14
Nikfarjam
M
,
Niumsawatt
V
,
Sethu
A
,
Fink
MA
,
Muralidharan
V
,
Starkey
G
et al
.
Outcomes of contemporary management of gangrenous and non-gangrenous acute cholecystitis
.
HPB (Oxford)
2011
;
13
(
8
):
551
558
15
Fry
DE
,
Cox
RA
,
Harbrecht
PJ
.
Gangrene of the gallbladder: a complication of acute cholecystitis
.
South Med J
1981
;
74
(
6
):
666
668
16
Haldestam
I
,
Enell
EL
,
Kullman
E
,
Borch
K
.
Development of symptoms and complications in individuals with asymptomatic gallstones
.
Br J Surg
2004
;
91
(
6
):
734
738
17
Eldar
S
,
Eitan
A
,
Bickel
A
,
Sabo
E
,
Cohen
A
,
Abrahamson
J
et al
.
The impact of patient delay and physician delay on the outcome of laparoscopic cholecystectomy for acute cholecystitis
.
Am J Surg
1999
;
178
(
4
):
303
307
18
Habib
FA
,
Kolachalam
RB
,
Khilnani
R
,
Preventza
O
,
Mittal
VK
.
Role of laparoscopic cholecystectomy in the management of gangrenous cholecystitis
.
Am J Surg
2001
;
181
(
1
):
71
75
19
Shpitz
B
,
Sigal
A
,
Kaufman
Z
,
Dinbar
A
.
Acute cholecystitis in diabetic patients
.
Am Surg
1995
;
61
(
11
):
964
967
20
Schwesinger
W
,
Diehl
A
.
Changing indications for laparoscopic cholecystectomy
.
Surg Clin North Am
1996
;
76
(
3
):
493
504
21
Bickel
A
,
Rappaport
A
,
Kanievski
V
,
Vaksman
I
,
Haj
M
,
Geron
N
et al
.
Laparoscopic management of acute cholecystitis: prognostic factors for success
.
Surg Endosc
1996
;
10
(
11
):
1045
1049
22
Schafer
M
,
Krahenbuhl
L
,
Buchler
MW
.
Predictive factors for the type of surgery in acute cholecystitis
.
Am J Surg
2001
;
182
(
3
):
291
297
23
Girgin
S
,
Gedik
E
,
Taçyıldız
IH
,
Akgün
Y
,
Baç
B
,
Uysal
E
.
Factors affecting morbidity and mortality in gangrenous cholecystitis
.
Acta Chir Belg
2006
;
106
(
5
):
545
549
24
Yusoff
IF
,
Barkun
JS
,
Barkun
AN
.
Diagnosis and management of cholecystitis and cholangitis
.
Gastroenterol Clin North Am
2003
;
32
(
4
):
1145
1168
25
Indar
AA
,
Beckingham
IJ
.
Acute cholecystitis
.
BMJ
2002
;
325
(
7365
):
639
643
26
Zufarov
KA
,
Sadriddinov
AF
.
Morphogenesis of hepatocellular necrosis in patients with cholelithiasis complicated by gangrenous cholecystitis
.
Arkh Patol
1987
;
49
(
4
):
55
61
27
Singer
J
,
Mckeen
R
.
Laparoscopic cholecystectomy for acute or gangrenous cholecystitis
.
Am Surg
1994
;
60
(
5
):
326
328
28
Eldar
S
,
Sabo
E
,
Nash
E
,
Abrahamson
J
,
Matter
I
.
Laparoscopic cholecystectomy for the various types of gall bladder inflammation: a prospective trial
.
Surg Laparosc Endosc
1998
;
8
(
3
):
200
207
29
Tazuma
S
.
Gallstone disease: epidemiology, pathogenesis, and classification of biliary stones (common bile duct and intrahepatic)
.
Best Pract Res Clin Gastroenterol
2006
;
20
(
6
):
1075
1083
30
Atamanalp
SS
,
Yıldırgan
,
Kantarcı
A
.
Endoscopic retrograde cholangiopancreatography (ERCP): outcomes of 3136 cases over 10 years
.
Turk J Med Sci
2011
;
41
(
4
):
615
621
31
Nguyen
L
,
Fagan
SP
,
Timothy
CL
,
Aoki
N
,
Itania
KMF
,
Berger
DH
et al
.
Use of a predictive equation for diagnosis of acute gangrenous cholecystitis
.
Am J Surg
2004
;
188
(
5
):
463
466
32
Bhattacharya
D
,
Senapati
PS
,
Hurle
R
,
Ammori
BJ
.
Urgent versus interval laparoscopic cholecystectomy for acute cholecystitis: a comparative study
.
J Hepatobiliary Pancreat Surg
2002
;
9
(
5
):
538
542